* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, July 6, 2025
Earth-News
  • Home
  • Business
  • Entertainment
  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    EIFO invests $5 million in D3, the Ukraine-focused defence technology venture fund – sUAS News

    EIFO Pledges $5 Million to Supercharge Ukraine-Focused Defense Technology Fund

    New Technology for Water Efficiency and Working with Mexico on Screwworm – AG INFORMATION NETWORK OF THE WEST

    Revolutionary Water Efficiency Technology and Cross-Border Collaboration to Defeat Screwworm

    Environmental cognitive distance, R&D capability distance, and supply chain green technology innovation – Nature

    Bridging Gaps: How Environmental and R&D Differences Drive Green Technology Innovation in Supply Chains

    LG Innotek CEO Moon Hyuksoo: “Our Next-gen Substrate Technology Will Change the Industry Paradigm” – TechPowerUp

    LG Innotek CEO Moon Hyuksoo: “Our Next-Gen Substrate Technology Will Revolutionize the Industry” Revolutionizing the Future: LG Innotek’s CEO Unveils Game-Changing Next-Gen Substrate Technology

    Inspira Technologies Secures Landmark $22.5M Deal: Major Revenue Breakthrough After FDA Clearance – Stock Titan

    Inspira Technologies Secures Landmark $22.5M Deal: Major Revenue Breakthrough After FDA Clearance – Stock Titan

    Meiwu Technology Company Limited and Shenzhen Zhinuo – GlobeNewswire

    Meiwu Technology Company Limited and Shenzhen Zhinuo – GlobeNewswire

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    EIFO invests $5 million in D3, the Ukraine-focused defence technology venture fund – sUAS News

    EIFO Pledges $5 Million to Supercharge Ukraine-Focused Defense Technology Fund

    New Technology for Water Efficiency and Working with Mexico on Screwworm – AG INFORMATION NETWORK OF THE WEST

    Revolutionary Water Efficiency Technology and Cross-Border Collaboration to Defeat Screwworm

    Environmental cognitive distance, R&D capability distance, and supply chain green technology innovation – Nature

    Bridging Gaps: How Environmental and R&D Differences Drive Green Technology Innovation in Supply Chains

    LG Innotek CEO Moon Hyuksoo: “Our Next-gen Substrate Technology Will Change the Industry Paradigm” – TechPowerUp

    LG Innotek CEO Moon Hyuksoo: “Our Next-Gen Substrate Technology Will Revolutionize the Industry” Revolutionizing the Future: LG Innotek’s CEO Unveils Game-Changing Next-Gen Substrate Technology

    Inspira Technologies Secures Landmark $22.5M Deal: Major Revenue Breakthrough After FDA Clearance – Stock Titan

    Inspira Technologies Secures Landmark $22.5M Deal: Major Revenue Breakthrough After FDA Clearance – Stock Titan

    Meiwu Technology Company Limited and Shenzhen Zhinuo – GlobeNewswire

    Meiwu Technology Company Limited and Shenzhen Zhinuo – GlobeNewswire

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Promising Phase 2 Results for Myasthenia Gravis Med

January 10, 2024
in Health
Promising Phase 2 Results for Myasthenia Gravis Med
Share on FacebookShare on Twitter

TOPLINE:

The monoclonal antibody nipocalimab improves scores related to activities of daily living in a dose-dependent manner, lowers relevant autoantibody levels, and has an acceptable safety and tolerability profile in patients with generalized myasthenia gravis (gMG), results of a phase 2 trial suggested.

METHODOLOGY:

The double-blind phase 2 study (Vivacity-MG) included 68 adults with gMG, most (94.1%) positive for anti-acetylcholine receptor (anti-AChR) autoantibodies, who had inadequate response to ongoing standard-of-care (SOC) therapy at 38 sites in eight countries.Subjects were randomized to receive infusions of placebo every 2 weeks (Q2W) or one of four regimens of nipocalimab, a human, antineonatal Fc receptor monoclonal antibody designed to inhibit IgG (5 mg/kg every 4 weeks [Q4W], 30 mg/kg Q4W, 60 mg/kg Q2W, or 60 mg/kg single dose) over 8 weeks in addition to SOC therapy.Researchers collected blood and serum samples and assessed total IgG levels, levels of anti-AChR and anti–muscle-specific kinase autoantibodies, and antidrug antibodies and neutralizing antibodies to nipocalimab.The primary efficacy endpoint was change to day 57 in total MG-Activities of Daily Living (MG-ADL) scores, with researchers analyzing dose response with a linear trend test.The primary safety outcome was treatment-emergent adverse events (TEAEs).

TAKEAWAY:

In the 83.8% of patients who completed treatment to day 57, there was a significant linear trend in the MG-ADL total score (P=.03) for the 5 mg/kg Q4W, 30 mg/kg Q4W, and 60 mg/kg Q2W groups (changes were not statistically significant compared with placebo, but the authors noted the study wasn’t powered to compare each nipocalimab group with placebo).The overall incidence of TEAEs was similar between the combined nipocalimab group (83.3%) and placebo group (78.6%) with no TEAEs leading to death or discontinuations; the most frequent TEAEs in the combined nipocalimab group were diarrhea, headache, and nasopharyngitis (11.1% each), but all were mild or moderate.The percentage of infections in the combined nipocalimab group was comparable with that in the placebo group with the most common infection being nasopharyngitis.Treatment with nipocalimab resulted in a marked, rapid, and dose-dependent reduction in serum total IgG levels (with a maximal reduction [83%] in the 60 mg/kg Q2W dose group) and corresponding dose-dependent reductions in anti-AChR autoantibodies.

IN PRACTICE:

“This study provides class I evidence that for patients with gMG, nipocalimab was well-tolerated, and it did not significantly improve MG-ADL at any individual dose but demonstrated a significant dose response for improved MG-ADL across doses,” wrote the authors, adding a phase 3 confirmatory study for nipocalimab in the treatment of gMG is ongoing.

SOURCE:

The study was carried out by Carlo Antozzi, MD, Neurological Institute Foundation C. Besta, Milan, Italy, and colleagues. It was published online on December 21, 2023, in Neurology.

LIMITATIONS:

Each study treatment group was relatively small, treatment duration (8 weeks) was short, and some study assessments were interrupted by COVID-19.

DISCLOSURES:

The study was funded by Momenta Pharmaceuticals, Inc., which is now part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Antozzi has received a travel grant from Biogen; see paper for disclosures of other authors.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/promising-phase-2-results-myasthenia-gravis-med-2024a10000k5

Tags: healthphasePromising
Previous Post

Side Effects of Local Therapy for Prostate Cancer May Linger

Next Post

The Benefits of Vitamin C

Israel’s economy can’t survive a long war with Iran – and Trump knows it – Middle East Eye

July 6, 2025
The long-term health risks as extreme heat becomes a new normal – PBS

Uncovering the Silent, Long-Term Health Risks of Life in Extreme Heat

July 6, 2025
Trump Says He Will Start Talks With China on TikTok Deal – The New York Times

Trump Says He Will Start Talks With China on TikTok Deal – The New York Times

July 6, 2025
EIFO invests $5 million in D3, the Ukraine-focused defence technology venture fund – sUAS News

EIFO Pledges $5 Million to Supercharge Ukraine-Focused Defense Technology Fund

July 6, 2025
Winning sports’ woke war is great, but unfortunately it’s led by the absurd – New York Post

The Thrilling Battle for Sports Culture Is Fueled by the Absurd

July 6, 2025
Tradition, ecology, and communion: the Church experiences a week of renewal and global commitment – exaudi.org

Tradition, Ecology, and Communion: The Church’s Inspiring Week of Renewal and Global Commitment

July 5, 2025
Shriners Children’s to Establish Research Institute at Science Square – Georgia Tech News Center

Shriners Children’s to Establish Research Institute at Science Square – Georgia Tech News Center

July 5, 2025
Scientists warn US will lose a generation of talent because of Trump cuts | Trump administration – The Guardian

Scientists Warn Trump-Era Cuts Threaten to Drain a Generation of American Talent

July 5, 2025
7 outdated boomer behaviors that were once normal but now feel tone-deaf – VegOut

7 Outdated Boomer Behaviors That Once Seemed Normal but Now Feel Completely Tone-Deaf

July 5, 2025
The Conversation: Freedom in the modern world – standard.net

Embracing Freedom in the Modern World: Challenges and Opportunities

July 5, 2025

Categories

Archives

July 2025
MTWTFSS
 123456
78910111213
14151617181920
21222324252627
28293031 
« Jun    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (706)
  • Economy (732)
  • Entertainment (21,621)
  • General (15,733)
  • Health (9,770)
  • Lifestyle (736)
  • News (22,149)
  • People (732)
  • Politics (741)
  • Science (15,949)
  • Sports (21,231)
  • Technology (15,716)
  • World (712)

Recent News

Israel’s economy can’t survive a long war with Iran – and Trump knows it – Middle East Eye

July 6, 2025
The long-term health risks as extreme heat becomes a new normal – PBS

Uncovering the Silent, Long-Term Health Risks of Life in Extreme Heat

July 6, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version